TBIO

Telesis Bio (TBIO)

Telesis Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TBIO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/13	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2024/06/11	09 : 40	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TBIO	Telesis Bio Inc
2024/06/11	09 : 30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TBIO	Telesis Bio Inc
2024/05/10	19 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TBIO	Telesis Bio Inc
2024/05/10	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Telesis Bio Reports First Quarter 2024 Financial Results	NASDAQ:TBIO	Telesis Bio Inc
2024/05/07	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2024/05/07	05 : 05	GlobeNewswire Inc.	Telesis Bio Announces Reverse Stock Split	NASDAQ:TBIO	Telesis Bio Inc
2024/04/18	22 : 00	GlobeNewswire Inc.	Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership	NASDAQ:TBIO	Telesis Bio Inc
2024/03/29	05 : 05	GlobeNewswire Inc.	Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:TBIO	Telesis Bio Inc
2024/03/06	08 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TBIO	Telesis Bio Inc
2024/03/06	08 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TBIO	Telesis Bio Inc
2024/03/06	08 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TBIO	Telesis Bio Inc
2024/03/01	10 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TBIO	Telesis Bio Inc
2024/03/01	10 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TBIO	Telesis Bio Inc
2024/02/27	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2024/02/26	23 : 15	GlobeNewswire Inc.	Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	NASDAQ:TBIO	Telesis Bio Inc
2023/12/01	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/11/14	06 : 32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TBIO	Telesis Bio Inc
2023/11/14	06 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/11/14	06 : 22	GlobeNewswire Inc.	Telesis Bio Reports Third Quarter 2023 Financial Results	NASDAQ:TBIO	Telesis Bio Inc
2023/11/10	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/11/07	23 : 00	GlobeNewswire Inc.	Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023	NASDAQ:TBIO	Telesis Bio Inc
2023/11/04	01 : 00	GlobeNewswire Inc.	Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA	NASDAQ:TBIO	Telesis Bio Inc
2023/10/25	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/09/29	04 : 48	GlobeNewswire Inc.	Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS	NASDAQ:TBIO	Telesis Bio Inc
2023/09/23	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/08/30	05 : 05	GlobeNewswire Inc.	Telesis Bio Appoints William J. Kullback Chief Financial Officer	NASDAQ:TBIO	Telesis Bio Inc
2023/08/30	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TBIO	Telesis Bio Inc
2023/08/11	19 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TBIO	Telesis Bio Inc